Xueqin Ma

Title: The Innovative Mind of Xueqin Ma: Pioneering Advances in Cyclodextrin Derivatives

Introduction: Xueqin Ma, an inventive mind from Jiangsu, China, has made significant strides in the field of chemistry and pharmaceuticals. With one patent to his name, he stands out for his work in developing hydroxypropyl-sulfobutyl-beta-cyclodextrin, a compound with numerous potential applications in the pharmaceutical industry.

Latest Patents: Xueqin Ma's patent, titled "Hydroxypropyl-sulfobutyl-beta-cyclodextrin, the preparation method, the analytical method, and the pharmaceutical application thereof," describes a novel derivative of cyclodextrin. This compound is characterized by the substitution of hydroxypropyl and sulfobutyl groups, represented as n-(2,3,6-O-2-hydroxypropyl)-m-(2,3,6-O-sulfobutyl)-beta-cyclodextrin. The unique formula permits the average substituent degree of hydroxypropyl groups (n) and sulfobutyl groups (m) to vary, thereby offering customizable properties. Notably, the invention showcases low haemolysis and low toxicity, making it an attractive candidate for pharmaceutical applications.

Career Highlights: Ma currently contributes his expertise to Hainan Hdeton Science and Technology Co., Ltd., where he applies his innovative approach to research and development. His work in developing cyclodextrin derivatives has the potential to revolutionize drug formulation, ensuring safer and more effective medications for various therapeutic uses.

Collaborations: Throughout his career, Xueqin Ma has collaborated with notable colleagues such as Yong Ren and Shuqin Yu, enhancing the depth of research and innovation in their projects. Together, they work to advance their understanding of cyclodextrin chemistry and its applications.

Conclusion: With a steadfast commitment to innovation, Xueqin Ma continues to push the boundaries of pharmaceutical research through his patents and collaborative efforts. His development of hydroxypropyl-sulfobutyl-beta-cyclodextrin highlights the importance of chemical innovation in producing safer and more effective pharmaceuticals. As he and his team explore new avenues of research, they pave the way for future advances in the field.